PKIA and Alzheimer disease: Because we demonstrated that blocking miR-155-5p ameliorated allergic inflammation in the AD model, we analyzed the effects of antagomir-155-5p on PKIα and TJ proteins in the elicitation stage (Fig. 6a) and initial stage of the AD model (Fig. 6b).